Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Mudde

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Pediatrics|July 5, 2021
Evolution of Our Understanding of XIAP DeficiencyAnne C A Mudde, Claire Booth, Rebecca A Marsh
Scandinavian Audiology|July 11, 2000
Reference data for DPOAE in healthy newbornsF Gordts, B Naessens, C A Mudde, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 21, 2024
What a Clinician Needs to Know About Genome Editing: Status and Opportunities for Inborn Errors of ImmunityAnne C A Mudde, Caroline Y Kuo, Donald B Kohn, et al.
The World Allergy Organization Journal|July 27, 2016
Eosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental modelsAnne C A Mudde, Willem S Lexmond, Richard S Blumberg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Pediatrics|July 5, 2021
Evolution of Our Understanding of XIAP DeficiencyAnne C A Mudde, Claire Booth, Rebecca A Marsh
Scandinavian Audiology|July 11, 2000
Reference data for DPOAE in healthy newbornsF Gordts, B Naessens, C A Mudde, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 21, 2024
What a Clinician Needs to Know About Genome Editing: Status and Opportunities for Inborn Errors of ImmunityAnne C A Mudde, Caroline Y Kuo, Donald B Kohn, et al.
The World Allergy Organization Journal|July 27, 2016
Eosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental modelsAnne C A Mudde, Willem S Lexmond, Richard S Blumberg, et al.
Pageof 1